What Lipid-lowering Therapy Is Best for Huge Low & Moderate Risk Population?
[Speaker] 박재형/고려의대
How Much Would Be Cost Effectiveness Important for New Lipid Lowering Agents?
[Speaker] 강현재/서울의대
Updated Evidence on Lipid Targets in Korean Studies
[Speaker] 김병극/연세의대
Discussion